AXOVANT SCIENCES LTD's ticker is AXGTXXXX and the CUSIP is G0750W104. A total of 101 filers reported holding AXOVANT SCIENCES LTD in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $13,000 | +30.0% | 10,700 | -0.9% | 0.00% | 0.0% |
| Q4 2018 | $10,000 | -60.0% | 10,800 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $25,000 | -24.2% | 10,800 | -63.3% | 0.00% | 0.0% |
| Q2 2018 | $33,000 | +22.2% | 29,400 | +41.3% | 0.00% | 0.0% |
| Q1 2018 | $27,000 | -64.5% | 20,800 | +26.0% | 0.00% | -33.3% |
| Q4 2017 | $76,000 | -91.0% | 16,504 | -92.6% | 0.00% | -90.6% |
| Q3 2017 | $849,000 | +21.3% | 223,379 | +272.1% | 0.03% | +23.1% |
| Q2 2017 | $700,000 | +165.2% | 60,025 | +61.0% | 0.03% | +136.4% |
| Q1 2017 | $264,000 | -32.3% | 37,274 | -45.4% | 0.01% | -21.4% |
| Q4 2016 | $390,000 | +170.8% | 68,260 | -14.0% | 0.01% | +133.3% |
| Q3 2016 | $144,000 | +414.3% | 79,389 | +958.5% | 0.01% | +500.0% |
| Q2 2016 | $28,000 | -90.1% | 7,500 | -91.4% | 0.00% | -94.7% |
| Q1 2016 | $283,000 | +253.8% | 86,754 | +820.2% | 0.02% | +280.0% |
| Q4 2015 | $80,000 | – | 9,428 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,000,000 | $57,400,000 | 7.34% |
| VHCP Management II, LLC | 429,590 | $4,932,000 | 3.24% |
| VHCP Management, LLC | 184,110 | $2,114,000 | 1.84% |
| Visium Asset Management, LP | 4,192,769 | $48,132,000 | 0.82% |
| Perceptive Advisors | 485,000 | $5,568,000 | 0.49% |
| Opus Point Partners Management, LLC | 26,416 | $303,000 | 0.23% |
| Virtus ETF Advisers LLC | 12,579 | $144,000 | 0.20% |
| BOURGEON CAPITAL MANAGEMENT LLC | 20,700 | $238,000 | 0.16% |
| AMERICAN FINANCIAL GROUP INC | 172,395 | $1,980,000 | 0.15% |
| NJ State Employees Deferred Compensation Plan | 51,000 | $640,000 | 0.14% |